Akari Therapeutics, Plc

AKTXNASDAQHealthcare● Active

$15.45

+$0.38(+2.49%)

Market Cap$17678146

P/E Ratio—

52W High$52

52W Low$3.015

Avg Volume764K

Open$15.08

Beta1.33

Forecast Market Cap PE Ratio

Akari Therapeutics, Plc（AKTX）股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

aktx · 股价预测 · 8 位分析师（近3月）· FMP · 更新于 2026年6月9日

分析师评级与共识

基于过去 3 个月内 8 位华尔街分析师

Buy

8 位分析师

共识

评级分布

Strong Buy

Buy

Hold

Sell

Strong Sell

合计: 8 · 买入占比: 75.0%

12 个月目标价

High

$1200

Consensus

$1200

+7669.5% upside

Low

$1200

Median: $1200 · Last Close: $15.45

Akari Therapeutics, Plc（AKTX）的分析师共识为 Buy，基于过去 3 个月内 8 位华尔街分析师的评级。AKTX 的 12 个月平均目标价为 $1200.00，相对当前价 $15.45 代表 +7669.5% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足，无法为该股票生成预测图表。

短期股价预测

算法生成 · 每日更新

Date	Predicted Price	Change	Min	Max
2026-06-10	$15.45	↑ 0.00%	$14.98	$15.91

1-day model range: $14.98–$15.91. Peak: $15.91 (+0.00%).

长期股价预测

⚠️ 在满 252 个交易日历史（IPO/上市时间较短）前不展示长期预测；短期标签页仍可能显示模型输出。

基于技术分析的股价预测

14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明

Market Sentiment

NEUTRAL

Based on 14 technical indicators

7%72%21%

1Buy

10Neutral

3Sell

RSI (14)50.0Neutral

MACDNEUTRAL

Refreshes daily from EOD close

Moving Averages · AKTX · Jun 9, 2026

Simple Moving Average (SMA)

MA 5$15.19BUY

MA 10$16.16SELL

MA 20$0.00NEUTRAL

MA 50$0.00NEUTRAL

MA 100$0.00NEUTRAL

MA 200$0.00NEUTRAL

Current $AKTX · Price above MA = BUY signal

Exponential Moving Average (EMA)

EMA 5$15.47SELL

EMA 10$16.26SELL

EMA 20$0.00NEUTRAL

EMA 50$0.00NEUTRAL

EMA 100$0.00NEUTRAL

EMA 200$0.00NEUTRAL

Current $AKTX · Price above MA = BUY signal

How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:

Date	Brokerage	Action	Rating
2026-04-08	Maxim Group	Downgrade ↓	Buy→Hold
2026-04-01	HC Wainwright & Co.	Maintains	Buy→Buy
2025-09-09	HC Wainwright & Co.	Maintains	Buy→Buy
2022-12-05	HC Wainwright & Co.	Maintains	Buy→Buy
2022-11-01	Alliance Global Partners	Maintains	Buy→Buy
2020-03-13	B. Riley FBR	Maintains	Buy→Buy
2020-03-13	B. Riley Securities	Maintains	Buy→Buy
2020-03-12	B. Riley Securities	Maintains	Buy→Buy
2018-05-05	B. Riley FBR	Maintains	Neutral→Neutral
2018-03-29	Canaccord Genuity	Maintains	Buy→Buy

Maxim Group2026-04-08

Downgrade ↓

Buy→Hold

HC Wainwright & Co.2026-04-01

Maintains

Buy→Buy

HC Wainwright & Co.2025-09-09

Maintains

Buy→Buy

HC Wainwright & Co.2022-12-05

Maintains

Buy→Buy

Alliance Global Partners2022-11-01

Maintains

Buy→Buy

B. Riley FBR2020-03-13

Maintains

Buy→Buy

B. Riley Securities2020-03-13

Maintains

Buy→Buy

B. Riley Securities2020-03-12

Maintains

Buy→Buy

B. Riley FBR2018-05-05

Maintains

Neutral→Neutral

Canaccord Genuity2018-03-29

Maintains

Buy→Buy

Wall Street analysts have recently issued updated ratings on Akari Therapeutics, Plc (AKTX) stock. Of the recent 17 rating actions, 2 were upgrades and 3 were downgrades. 8 analysts currently cover AKTX.

分析师推荐趋势

Buy ratings0 → 1↑ +1

Hold ratings1 → 1

Sell ratings0 → 0

AKTX analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 1 per month.

财务预测：EPS 与营收一致预期

Revenue This Year

$10M

Revenue Next Year

$0M

↓ 100.0% YoY

EPS This Year

$-5.77

EPS Next Year

$-4.68

↓ 18.9% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast AKTX EPS of $-5.77 for the current fiscal year, based on estimates from 2 analysts. The AKTX revenue forecast is $10M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

AKTX 股价预测由两类独立数据源支撑：来自 8 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。AKTX 的共识目标价为 $1200.00（+7669.5% 上行空间），分析师共识为 Buy。

AKTX 的短期预测（明日）为 $15.45（+0.00%）。

Akari Therapeutics, Plc 在 NASDAQ 上市，代码 AKTX。AKTX 在 2027 年的整体展望偏积极，在覆盖分析师中约 75% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

AKTX 预测 · 8 个问题

根据 8 位华尔街分析师，AKTX 的 12 个月平均目标价为 $1200.00，最高 $1200.00、最低 $1200.00。若有图表，中位目标价可在上方查看。相对当前价 $15.45，隐含约 +7669.5% 的上行空间。

AKTX 目标价AKTX 分析师目标价AKTX 12个月目标价目标价 AKTX

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.